For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But with the growing popularity and effectiveness of medications like semaglutide ...

New ICD-10 diagnosis code is for patients with history of type 2 diabetes who bring blood sugar levels to a non-diabetic ...

Intermittent fasting has gained popularity among individuals who want to lose weight. While this approach has shown promising results, it may not be the best eating plan for everyone. When discussing ...

Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

Please provide your email address to receive an email when new articles are posted on . Use of GLP-1 drugs was linked to a 23% lower mortality risk for adults with type 2 diabetes on dialysis. The ...

An epidemic of Type 2 diabetes continues to plague the United States, leading to calls for reassessing how the disease is ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Mifepristone reduced HbA1c and weight in patients with ...

The FDA has approved oral semaglutide (Rybelsus) 7 mg and 14 mg tablets to lower the risk of cardiovascular death, heart attack, or stroke in high-risk adults with type 2 diabetes-marking the ...

Jim Cox had heard of people with Type 2 diabetes who were unable to get Ozempic because the drug was being used off-label for weight loss. He just didn't think the shortage would affect him. He has ...

Could a diabetes drug slash your cancer risk? New research shows GLP-1 receptor agonists may protect patients with type 2 diabetes from deadly blood cancers—beyond just managing blood sugar.

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases ...